FATE
Fate Therapeutics Inc. (FATE)
NASDAQ · Healthcare
Fate Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fate Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 1.3 M, a 20.26% decrease year-over-year.
- Fate Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 6.6 M, a 52.05% decrease year-over-year.
- Fate Therapeutics Inc. annual revenue for 2025 was 6.6 M, a 51.24% decrease from 2024.
- Fate Therapeutics Inc. annual revenue for 2024 was 13.6 M, a 78.55% decrease from 2023.
- Fate Therapeutics Inc. annual revenue for 2023 was 63.5 M, a 34.03% decrease from 2022.
- Fate Therapeutics Inc. annual revenue for 2022 was 96.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fate Therapeutics Inc. Market Cap — FAQ
Fate Therapeutics Inc. (FATE) market cap over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FATE's market cap history?
The chart and table above show Fate Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.